CRH Medical Corp (CRHM) Stock Price & Overview
NYSEARCA:CRHM
Current stock price
The current stock price of CRHM is 3.99 null. Today CRHM is down by 0%. In the past month the price increased by 1.53%. In the past year, price increased by 102.54%.
CRHM Key Statistics
- Market Cap
- 285.764M
- P/E
- N/A
- Fwd P/E
- 399.00
- EPS (TTM)
- -0.04
- Dividend Yield
- N/A
CRHM Stock Performance
CRHM Stock Chart
CRHM Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to CRHM. When comparing the yearly performance of all stocks, CRHM is one of the better performing stocks in the market, outperforming 87.83% of all stocks.
CRHM Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CRHM. The financial health of CRHM is average, but there are quite some concerns on its profitability.
CRHM Earnings
CRHM Forecast & Estimates
CRHM Financial Highlights
Over the last trailing twelve months CRHM reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS decreased by -180% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -23.05% | ||
| ROA | -12.76% | ||
| ROE | N/A | ||
| Debt/Equity | 0.67 |
CRHM Ownership
About CRHM
Company Profile
CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. At the end of 2018, CRH had completed 20 anesthesia acquisitions and served 46 ambulatory surgical centers in ten states, performing approximately 305,000 procedures annually. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.
Company Info
CRH Medical Corp
619 - 999 CANADA PLACE WORLD TRADE CENTER
VANCOUVER A1 V6C 3E1
CEO: Tushar Ramani
Phone: 604-633-1440
CRH Medical Corp / CRHM FAQ
What does CRHM do?
CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. At the end of 2018, CRH had completed 20 anesthesia acquisitions and served 46 ambulatory surgical centers in ten states, performing approximately 305,000 procedures annually. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete, turnkey package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.
What is the stock price of CRH Medical Corp today?
The current stock price of CRHM is 3.99 null.
Does CRH Medical Corp pay dividends?
CRHM does not pay a dividend.
What is the ChartMill rating of CRH Medical Corp stock?
CRHM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists CRHM stock?
CRHM stock is listed on the NYSE Arca exchange.
What is the Price/Earnings (PE) ratio of CRH Medical Corp (CRHM)?
CRH Medical Corp (CRHM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).